Long-term weight loss study for trial participants
Treatments studied
Part of Hormones & metabolism clinical trials.
This study is for people who finished a previous weight loss trial and want to continue treatment with an injectable medication GZR18. It tests how well the medicine works over a longer period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken part in the earlier weight loss study and completed all doses.
- Your body mass index (BMI) must be above 18.5 at the end of the earlier study.
- You cannot be pregnant, plan to get pregnant, or donate eggs or sperm during the study and for 8 weeks after.
- You must be willing to get regular injections, follow a healthy diet and exercise plan, and sign a consent form.
- You cannot have used the weight loss drug semaglutide (Wegovy) in the earlier study.
- You must not have diabetes or high blood sugar levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This trial tests a new weekly injection called GZR18 against the existing drug Wegovy for weight loss in adults who are overweight or obese. It aims to see which is more effective and safe for helping people lose weight and improve related health conditions.
This trial tests a new injection (GZR102) compared to two other injections (GZR4 and GZR18) in overweight adults. The goal is to see how well the body processes each drug and their effects. It may help researchers find a better treatment for weight management.
This study tests an investigational medication called GZR18, which is a once-weekly injection that may help with weight loss and improve sleep apnea. It is for people with obesity and sleep apnea who are not using a CPAP machine.
This trial tests how a new drug called GZR18 (given as an injection) affects the body in people with different levels of kidney function. It aims to find the right dose and check for side effects, which could help guide treatment for people with kidney issues.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.